Avg closing price

Price range

9 Seth Klarman Theravance Biopharma Inc transactions

Avg closing price
Price range
Increased shares by 13.5% (+1.18 Million shares) Q2 2021

Avg closing price

$18.78

Price range

$14.52 - $22.46
Sold 6.2% shares (-574 Thousand shares) Q3 2020

Avg closing price

$18.73

Price range

$14.78 - $22.49
Increased shares by 0.4% (+35.2 Thousand shares) Q3 2017

Avg closing price

$32.70

Price range

$23.88 - $42.56
Increased shares by 26.2% (+1.92 Million shares) Q4 2016

Avg closing price

$31.02

Price range

$24.57 - $38.58
Increased shares by 13.1% (+850 Thousand shares) Q2 2016

Avg closing price

$21.59

Price range

$17.45 - $24.20
Increased shares by 1.3% (+81 Thousand shares) Q1 2016

Avg closing price

$16.36

Price range

$13.35 - $18.80
Increased shares by 0.8% (+53.5 Thousand shares) Q2 2015

Avg closing price

$15.51

Price range

$12.57 - $18.63
Increased shares by 5.0% (+305 Thousand shares) Q1 2015

Avg closing price

$18.33

Price range

$14.70 - $21.73
New holding (+6.06 Million shares) Q2 2014

Avg closing price

$30.10

Price range

$23.51 - $34.87

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!